PPIDT00029
Drug Information
| Name | Tenecteplase |
|---|---|
| Sequence | SYQVICRDEKTQMIYQQHQSWLRPVLRSNRVEYCWCNSGRAQCHSVPVKSCSEPRCFNGGTCQQALYFSDFVCQCPEGFAGKCCEIDTRATCYEDQGISYRGNWSTAESGAECTNWQSSALAQKPYSGRRPDAIRLGLGNHNYCRNPDRDSKPWCYVFKAGKYSSEFCSTPACSEGNSDCYFGNGSAYRGTHSLTESGASCLPWNSMILIGKVYTAQNPSAQALGLGKHNYCRNPDGDAKPWCHVLKNRRLTWEYCDVPSCSTCGLRQYSQPQFRIKGGLFADIASHPWQAAIFAAAAASPGERFLCGGILISSCWILSAAHCFQERFPPHHLTVILGRTYRVVPGEEEQKFEVEKYIVHKEFDDDTYDNDIALLQLKSDSSRCAQESSVVRTVCLPPADLQLPDWTECELSGYGKHEALSPFYSERLKEAHVRLYPSSRCTSQHLLNRTVTDNMLCAGDTRSGGPQANLHDACQGDSGGPLVCLNDGRMTLVGIISWGLGCGQKDVPGVYTKVTNYLDWIRDNMRP |
| DrugBank_ID | DB00031 |
| Type | biotech |
| Indication | For treatment of myocardial infarction and lysis of intracoronary emboli |
Dosage Forms
| Form | Route | Strength |
|---|---|---|
| Injection, powder, for solution | — |
10000 IU
|
| Injection, powder, for solution | Intravenous |
10000 units
|
| Injection, powder, for solution | Intravenous |
5000 units
|
| Injection, powder, for solution | Intravenous |
8000 units
|
| Injection, powder, for solution | Intravenous; Parenteral |
10000 U/10ML
|
| Injection, powder, for solution | Intravenous; Parenteral |
6000 U/6ML
|
| Injection, powder, for solution | Intravenous; Parenteral |
8000 U/8ML
|
| Powder | Intravenous |
10000 U/10ML
|
| Powder | Intravenous |
6000 U/6ML
|
| Powder | Intravenous |
8000 U/8ML
|
| Solution | Intravenous |
30.000 mg
|
| Injection, powder, for solution | — |
5 mg/mL
|
| Injection, powder, for solution | Intravenous bolus |
50 mg
|
| Injection, powder, for solution | Parenteral |
3000000 mg
|
| Injection, powder, lyophilized, for solution | Parenteral |
4000000 mg
|
| Injection, powder, for solution | Intravenous |
10000 u
|
| Injection, powder, lyophilized, for solution | Intravenous |
5000000 mg
|
| Injection, powder, for solution | Intravenous |
|
| Powder | Intravenous |
|
| Injection, powder, lyophilized, for solution; kit | Intravenous |
52.5 mg/50mg
|
| Kit | Intravenous; Topical |
|
| Powder, for solution | Intravenous |
50 mg / vial
|
| Powder | Intravenous |
40 mg/1vial
|